|
Re: Not predicting another short attack....
|
5
|
Resverlogix Corp.
|
Aug 23, 2018 02:20PM
|
|
Re: Seeking Alpha post
|
1
|
Resverlogix Corp.
|
Aug 27, 2018 02:39PM
|
|
Zenith/JNJ
|
5
|
Zenith Epigenetics
|
Aug 27, 2018 05:40PM
|
|
Re: Resverlogix H2 2018 events
|
6
|
Resverlogix Corp.
|
Aug 29, 2018 12:53AM
|
|
Blistering volume today
|
4
|
Resverlogix Corp.
|
Aug 29, 2018 01:51PM
|
|
Re: Blistering volume today
|
2
|
Resverlogix Corp.
|
Aug 29, 2018 09:29PM
|
|
Re: Private placement
|
6
|
Resverlogix Corp.
|
Aug 30, 2018 09:54AM
|
|
Re: Blistering volume today
|
3
|
Resverlogix Corp.
|
Aug 30, 2018 03:43PM
|
|
Failure of AZN's anifrolumab could be good for RVX
|
6
|
Resverlogix Corp.
|
Aug 31, 2018 03:57PM
|
|
Re: Zenith MD&A posted to SEDAR 8/23/18
|
5
|
Zenith Epigenetics
|
Sep 01, 2018 01:35PM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
3
|
Zenith Epigenetics
|
Sep 03, 2018 12:50AM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
3
|
Zenith Epigenetics
|
Sep 03, 2018 11:22PM
|
|
Re: holy jumping cheese curds, what a jump to $3.75
|
6
|
Resverlogix Corp.
|
Sep 05, 2018 01:09PM
|
|
Re: Here's to New 52 week highs
|
6
|
Resverlogix Corp.
|
Sep 05, 2018 02:23PM
|
|
NY presentation
|
2
|
Resverlogix Corp.
|
Sep 07, 2018 02:37PM
|
|
The Shorts
|
4
|
Resverlogix Corp.
|
Sep 07, 2018 02:46PM
|
|
Re: Spike
|
6
|
Resverlogix Corp.
|
Sep 09, 2018 01:36PM
|
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
4
|
Resverlogix Corp.
|
Sep 09, 2018 10:50PM
|
|
OTC Pinks
|
2
|
Resverlogix Corp.
|
Sep 11, 2018 11:05AM
|
|
Re: Zenith AGM webcast 9/12/2018
|
5
|
Zenith Epigenetics
|
Sep 12, 2018 07:29PM
|
